Category: Cardiac ImplantsSyndicate content

Medtronic touts real-world study of Reveal Linq heart monitor

February 11, 2015 by Brad Perriello

Medtronic touts a real-world study of its Reveal Linq insertable cardiac monitor for detecting atrial fibrillation and says a separate analysis shows that long-term implanted cardiac monitoring is cost-effective.

Medtronic touts real-world study of Reveal Linq monitor

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Positive data for Neovasc study of stent-like angina device

February 9, 2015 by Mark Hollmer

Neovasc reports positive data from a study of its stent-like device to treat refractory angina were published in the New England Journal of Medicine.

Positive data for Neovasc study of stent-like angina device

Neovasc (NYSE:NVC) said its device to treat refractory angina – implanted much like a coronary stent – met the endpoints in a clinical trial involving 104 patients.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

SynCardia wins FDA nod for destination therapy trial

January 7, 2015 by Mark Hollmer

SynCardia gains the FDA's O.K. to test its artificial heart as a permanent implant in 19 patients.

SynCardia wins FDA nod for destination therapy trial

SynCardia plans to test its artificial heart as a permanent implant rather than a placeholder for donor transplants in 19 patients.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Sorin wins FDA nod for Memo3d ReChord mitral annuloplasty ring

December 18, 2014 by Mark Hollmer

Sorin Group is beginning a U.S. rollout of a new surgical implant ring for addressing mitral valve repair issues.

Sorin wins FDA nod for Memo3d ReChord annuloplasty ring

Italy's Sorin Group (BIT:SRN) nailed down FDA clearance for a new surgical implant designed for use in mitral valve repair.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

UPDATE: 3rd FDA panel vote barely favors Boston Scientific's Watchman anti-stroke device

October 9, 2014 by Brad Perriello

An FDA advisory panel's unprecedented 3rd hearing over Boston Scientific's Watchman anti-stroke device barely favors the cardiac implant.

UPDATE: 3rd FDA panel vote barely favors Boston Scientific's Watchman anti-stroke device

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA panel offers mixed view on Boston Scientific Watchman device

October 8, 2014 by MassDevice

An FDA advisory panel gives a mixed view in its unprecedented 3rd review of Boston Scientific's Watchman anti-stroke device.

FDA panel offers mixed view on Boston Scientific Watchman device

FDA doubtful on new Watchman data from Boston Scientific

October 6, 2014 by Brad Perriello

The FDA expresses some doubts about new data from Boston Scientific on its Watchman anti-stroke device.

FDA doubtful on new Watchman data from Boston Scientific

Get the complete picture with a MassDevice Plus membership. Registered users can login here.